Deans' stroke musings: Sleep disorders in stroke rehabilitation: mechanisms, impacts, and multidisciplinary management

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, September 14, 2026

Sleep disorders in stroke rehabilitation: mechanisms, impacts, and multidisciplinary management — a narrative review

Are you that brilliantly stupid you think describing sleep problems gets anyone recovered? WOW! That's special!

I'd have you all fired!

Sleep disorders in stroke rehabilitation: mechanisms, impacts, and multidisciplinary management — a narrative review

Department of Geriatric Rehabilitation, Shanghai Second Rehabilitation Hospital, Shanghai, China

Abstract

Background:

Sleep disorders and stroke share a bidirectional relationship. Sleep disturbances are independent stroke risk factors and frequent post-stroke complications. Obstructive sleep apnea (OSA), through intermittent hypoxia, systemic inflammation, endothelial dysfunction, and autonomic dysregulation, increases stroke risk by approximately 2- to 3-fold. Post-stroke sleep disorders affect up to 59.9% of patients, impeding neurological recovery.

Objectives:

To examine the epidemiology, pathophysiology, and clinical impacts of sleep disorders on stroke recovery, and to summarize evidence-based management strategies.

Methods:

A narrative review was guided by a writing outline developed from clinical observations and preliminary synthesis. A theme-driven literature search was conducted in PubMed, Embase, Cochrane, Web of Science, CNKI, and Wanfang (March 10–13, 2026) using targeted keywords (e.g., “sleep disorders,” “obstructive sleep apnea,” “rehabilitation,” “stroke”), limited to 2000–2026 publications in English or verified Chinese translations. Reference lists were also screened.

Results:

Post-stroke sleep disorder prevalence ranges from 25 to 84%; OSA affects 40–78% of stroke patients. Sleep disorders correlate with worse functional outcomes, prolonged hospitalization, cognitive decline, and elevated stroke recurrence. Mechanistically, intermittent hypoxia, oxidative stress, systemic inflammation, glymphatic dysfunction, autonomic dysregulation, and impaired neuroplasticity are implicated. Management: CPAP is first-line for OSA; CBT-I improves insomnia symptoms; rTMS has been shown to improve sleep quality in clinical studies; exercise, melatonin, and light therapy show emerging evidence. Pharmacotherapy for RLS/PLMD requires caution regarding fall risk and cognitive side effects.

Conclusion:

Sleep disorders are highly prevalent and negatively impact stroke recovery. Evidence-based strategies—CPAP, CBT-I, and rTMS—improve sleep and functional outcomes, though evidence heterogeneity exists. High-quality RCTs are needed to optimize individualized protocols.